Seeking Alpha

Qiagen and Lilly team up

  • Qiagen (QGEN) and Eli Lilly (LLY) collaborate to co-develop universal and modular assay panels for the simultaneous analysis of DNA and RNA biomarkers targeting multiple cellular pathways involved in common cancer types. The agreement includes tests based on QGEN's multi-modal multi-analyte Modaplex analysis platform which can process multiple sample types and biomarkers in a single test.
  • This is the fourth collaboration between the two companies.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio: